Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Hansheng Pharmaceutical is a Chinese pharmaceutical manufacturer specializing in the production of chemical drug formulations, with a particular focus on cardiovascular and analgesic therapies. The company is the primary producer of Aluminum Magnesium Aspirin Tablets (II), a specialized buffered aspirin formulation designed to minimize gastrointestinal side effects while providing antiplatelet and analgesic benefits. Hansheng operates large-scale, GMP-certified manufacturing facilities in Zhejiang province and supplies a variety of generic medications to the Chinese healthcare system. Their business model centers on high-quality generic production and the optimization of established therapeutic compounds for better patient tolerability. The company's portfolio includes several oral solid dosage forms targeting chronic conditions prevalent in the aging population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aluminum Magnesium Aspirin Tablets II.